. | Female, % (n) . | Age, mean (SD) . | Age≥60 years, % (n) . |
---|---|---|---|
Centre | |||
Bosnia and Herzegovinad | 53.2 (118/222) | 62.3 (8.9) | 58.1 (129/222) |
Bulgaria | 49.5 (93/188) | 60.0 (12.2) | 60.6 (114/188) |
Croatia | 57.9 (232/401) | 62.7 (10.1) | 64.1 (257/401) |
Kazakhstan | 68.3 (285/417) | 57.2 (9.1) | 39.8 (166/417) |
Lithuania | 55.8 (223/400) | 54.0 (9.1) | 28.3 (113/400) |
Poland | 55.8 (261/468) | 56.8 (10.5) | 42.9 (201/468) |
Portugal | 53.8 (211/392) | 65.9 (9.4) | 75.5 (296/392) |
Romania | 60.2 (239/397) | 55.5 (12.5) | 39.5 (157/397) |
Russian Federation | 71.6 (290/405) | 56.0 (10.1) | 30.4 (123/405) |
Serbia | 57.2 (103/180) | 51.0 (14.2) | 30.6 (55/180) |
Spain | 46.6 (75/161) | 66.9 (8.9) | 76.4 (123/161) |
Sweden | 51.3 (77/150) | 64.9 (9.0) | 72.7 (109/150) |
Ukraine | 64.1 (263/410) | 56.8 (11.4) | 43.4 (178/410) |
United Kingdom | 45.6 (177/388) | 61.0 (11.5) | 55.9 (217/388) |
Reasons for inclusion | |||
Blood pressure lowering therapy | 59.2 (1920/3243) | 58.9 (11.0) | 48.5 (1574/3243) |
Lipid-lowering therapy | 57.0 (676/1186) | 60.8 (10.7) | 56.2 (667/1186) |
Glucose-lowering therapy | 52.1 (570/1094) | 59.7 (11.7) | 52.7 (577/1094) |
All | 57.8 (2647/4579) | 58.8 (11.3) | 48.9 (2238/4579) |
. | Female, % (n) . | Age, mean (SD) . | Age≥60 years, % (n) . |
---|---|---|---|
Centre | |||
Bosnia and Herzegovinad | 53.2 (118/222) | 62.3 (8.9) | 58.1 (129/222) |
Bulgaria | 49.5 (93/188) | 60.0 (12.2) | 60.6 (114/188) |
Croatia | 57.9 (232/401) | 62.7 (10.1) | 64.1 (257/401) |
Kazakhstan | 68.3 (285/417) | 57.2 (9.1) | 39.8 (166/417) |
Lithuania | 55.8 (223/400) | 54.0 (9.1) | 28.3 (113/400) |
Poland | 55.8 (261/468) | 56.8 (10.5) | 42.9 (201/468) |
Portugal | 53.8 (211/392) | 65.9 (9.4) | 75.5 (296/392) |
Romania | 60.2 (239/397) | 55.5 (12.5) | 39.5 (157/397) |
Russian Federation | 71.6 (290/405) | 56.0 (10.1) | 30.4 (123/405) |
Serbia | 57.2 (103/180) | 51.0 (14.2) | 30.6 (55/180) |
Spain | 46.6 (75/161) | 66.9 (8.9) | 76.4 (123/161) |
Sweden | 51.3 (77/150) | 64.9 (9.0) | 72.7 (109/150) |
Ukraine | 64.1 (263/410) | 56.8 (11.4) | 43.4 (178/410) |
United Kingdom | 45.6 (177/388) | 61.0 (11.5) | 55.9 (217/388) |
Reasons for inclusion | |||
Blood pressure lowering therapy | 59.2 (1920/3243) | 58.9 (11.0) | 48.5 (1574/3243) |
Lipid-lowering therapy | 57.0 (676/1186) | 60.8 (10.7) | 56.2 (667/1186) |
Glucose-lowering therapy | 52.1 (570/1094) | 59.7 (11.7) | 52.7 (577/1094) |
All | 57.8 (2647/4579) | 58.8 (11.3) | 48.9 (2238/4579) |
SD: standard deviation.
. | Female, % (n) . | Age, mean (SD) . | Age≥60 years, % (n) . |
---|---|---|---|
Centre | |||
Bosnia and Herzegovinad | 53.2 (118/222) | 62.3 (8.9) | 58.1 (129/222) |
Bulgaria | 49.5 (93/188) | 60.0 (12.2) | 60.6 (114/188) |
Croatia | 57.9 (232/401) | 62.7 (10.1) | 64.1 (257/401) |
Kazakhstan | 68.3 (285/417) | 57.2 (9.1) | 39.8 (166/417) |
Lithuania | 55.8 (223/400) | 54.0 (9.1) | 28.3 (113/400) |
Poland | 55.8 (261/468) | 56.8 (10.5) | 42.9 (201/468) |
Portugal | 53.8 (211/392) | 65.9 (9.4) | 75.5 (296/392) |
Romania | 60.2 (239/397) | 55.5 (12.5) | 39.5 (157/397) |
Russian Federation | 71.6 (290/405) | 56.0 (10.1) | 30.4 (123/405) |
Serbia | 57.2 (103/180) | 51.0 (14.2) | 30.6 (55/180) |
Spain | 46.6 (75/161) | 66.9 (8.9) | 76.4 (123/161) |
Sweden | 51.3 (77/150) | 64.9 (9.0) | 72.7 (109/150) |
Ukraine | 64.1 (263/410) | 56.8 (11.4) | 43.4 (178/410) |
United Kingdom | 45.6 (177/388) | 61.0 (11.5) | 55.9 (217/388) |
Reasons for inclusion | |||
Blood pressure lowering therapy | 59.2 (1920/3243) | 58.9 (11.0) | 48.5 (1574/3243) |
Lipid-lowering therapy | 57.0 (676/1186) | 60.8 (10.7) | 56.2 (667/1186) |
Glucose-lowering therapy | 52.1 (570/1094) | 59.7 (11.7) | 52.7 (577/1094) |
All | 57.8 (2647/4579) | 58.8 (11.3) | 48.9 (2238/4579) |
. | Female, % (n) . | Age, mean (SD) . | Age≥60 years, % (n) . |
---|---|---|---|
Centre | |||
Bosnia and Herzegovinad | 53.2 (118/222) | 62.3 (8.9) | 58.1 (129/222) |
Bulgaria | 49.5 (93/188) | 60.0 (12.2) | 60.6 (114/188) |
Croatia | 57.9 (232/401) | 62.7 (10.1) | 64.1 (257/401) |
Kazakhstan | 68.3 (285/417) | 57.2 (9.1) | 39.8 (166/417) |
Lithuania | 55.8 (223/400) | 54.0 (9.1) | 28.3 (113/400) |
Poland | 55.8 (261/468) | 56.8 (10.5) | 42.9 (201/468) |
Portugal | 53.8 (211/392) | 65.9 (9.4) | 75.5 (296/392) |
Romania | 60.2 (239/397) | 55.5 (12.5) | 39.5 (157/397) |
Russian Federation | 71.6 (290/405) | 56.0 (10.1) | 30.4 (123/405) |
Serbia | 57.2 (103/180) | 51.0 (14.2) | 30.6 (55/180) |
Spain | 46.6 (75/161) | 66.9 (8.9) | 76.4 (123/161) |
Sweden | 51.3 (77/150) | 64.9 (9.0) | 72.7 (109/150) |
Ukraine | 64.1 (263/410) | 56.8 (11.4) | 43.4 (178/410) |
United Kingdom | 45.6 (177/388) | 61.0 (11.5) | 55.9 (217/388) |
Reasons for inclusion | |||
Blood pressure lowering therapy | 59.2 (1920/3243) | 58.9 (11.0) | 48.5 (1574/3243) |
Lipid-lowering therapy | 57.0 (676/1186) | 60.8 (10.7) | 56.2 (667/1186) |
Glucose-lowering therapy | 52.1 (570/1094) | 59.7 (11.7) | 52.7 (577/1094) |
All | 57.8 (2647/4579) | 58.8 (11.3) | 48.9 (2238/4579) |
SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.